Expression of Olig2, Nestin, NogoA and AQP4 have no impact on overall survival in IDH-wildtype glioblastoma.
Despite many years of research efforts and clinical trials the prognosis of patients diagnosed with glioblastoma remains very poor. The oligodendrocyte transcription factor 2 (Olig2) was identified as a marker for glioma stem cells, which are believed to be responsible for glioma recurrence and ther...
Main Authors: | Felix Behling, Alonso Barrantes-Freer, Carl Ludwig Behnes, Florian Stockhammer, Veit Rohde, Antonia Adel-Horowski, Odir Antonio Rodríguez-Villagra, Miguel Angel Barboza, Wolfgang Brück, Ulrich Lehmann, Christine Stadelmann, Christian Hartmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0229274 |
Similar Items
-
The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
by: Arne Christians, et al.
Published: (2019-10-01) -
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
by: Bill H. Diplas, et al.
Published: (2018-05-01) -
Extracellular Pgk1 enhances neurite outgrowth of motoneurons through Nogo66/NgR-independent targeting of NogoA
by: Cheng Yung Lin, et al.
Published: (2019-07-01) -
The role of surgery in IDH wildtype diffuse astrocytomas
by: Harald Krenzlin, et al.
Published: (2023-01-01) -
NogoA-expressing astrocytes limit peripheral macrophage infiltration after ischemic brain injury in primates
by: Anthony G. Boghdadi, et al.
Published: (2021-11-01)